Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

After treatment ends: neutral time

G J Hurt, R P McQuellon, R J Barrett

    Cancer Practice
    |November 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Cancer remission can cause anxiety due to fear of recurrence. The lack of safety signals, or clear indicators of health, contributes to this distress during "neutral time."

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivo.

    Journal of virology·2008
    Same author

    Providing psychosocial group support for young women with breast cancer: findings from a wellness-based community collaboration.

    Journal of psychosocial oncology·2007
    Same author

    Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)).

    Leukemia·2007
    Same author

    Mental health nurses' and psychiatrists' views on the prognosis of schizophrenia and depression: an exploratory, qualitative investigation.

    Journal of psychiatric and mental health nursing·2005
    Same author

    Evidence for PTZ-like cues as a function of time following treatment with chlordiazepoxide: implications for understanding tolerance and withdrawal.

    Behavioural pharmacology·2005
    Same author

    Collective danger and individual risk: cultural perspectives on the hazards of medical research.

    Internal medicine journal·2003
    Same journal

    Darbepoetin alfa: a review of its use in patients with cancer.

    Cancer practice·2002
    Same journal

    Cancer genetics: information sources for patients and families.

    Cancer practice·2002
    Same journal

    Bladder cancer: epidemiology, diagnosis, and management.

    Cancer practice·2002
    Same journal

    Patient and caregiver interest in internet-based cancer services.

    Cancer practice·2002
    Same journal

    Tapestry: a retreat program of support for persons living with cancer.

    Cancer practice·2002
    Same journal

    Viatical settlements: effects on terminally ill patients.

    Cancer practice·2002
    See all related articles

    Area of Science:

    • Psychology
    • Oncology

    Background:

    • Cancer remission is a critical phase, yet often brings psychological distress.
    • Patients may experience heightened anxiety and fear of recurrence despite medical milestones.

    Observation:

    • The remission period is termed "neutral time," characterized by uncertainty and reduced medical surveillance.
    • Cancer's silent nature means patients lack overt safety signals confirming disease non-recurrence.

    Findings:

    • Seligman's safety signal hypothesis may explain anxiety during remission.
    • The absence of clear health indicators intensifies fear of cancer returning.

    Implications:

    • Understanding patient anxiety in remission is crucial for supportive care.
  • Addressing the fear of recurrence can improve quality of life during survivorship.